| Phase I | Phase II | Phase III | Postapproval | Postmarket | Clinical registry |
Aim | Safety | Efficacy | Safety, efficacy and effectiveness | Effectiveness |
Inclusion criteria | Restrictive | Either | Broad |
Intervention | Tight protocol | Either | Implemented in usual clinical practice |
Cointervention | Based on protocols for many aspects of care | Either | Based on local practice; monitored but minimal control |
Adherence to protocol | Required | Either | Expected and considered in sample size and analysis plan |
Events | Related to biological effect (eg, conversion out of shockable rhythm) | Either | Related to patient outcome (eg, survival) |
Analysis | Treatment received | Both | Intention to treat |
Sample size | Usually <1000 | Either | Usually > 1000 |
Data burden | Large | Core supplemented by study-specific | Minimal and simple core |
Study management | Significant interventions and support from research staff | Minimal support and interventions from research team |